Literature DB >> 6605691

Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias.

P K Pattengale, C R Taylor.   

Abstract

The present review focuses on the mouse as an experimental immunopathologic model for human non-Hodgkin's lymphomas and related leukemias. Immunomorphologic evidence is presented that clearly demonstrates that B- and T-cell subtypes of mouse (murine) lymphoma/leukemia closely resemble and are analogous to B- and T-cell subtypes of human lymphoma/leukemia as defined by recently proposed immunomorphologic classifications. Further evidence is presented that favors the hypothesis that certain types of murine and human B-cell lymphoma develop out of prodromal, prelymphomatous states, which exhibit antecedent morphologic and immunologic abnormalities. The many experimental advantages of the murine systems are stressed, as well as the concept that the presently defined immunomorphologic approach should be effectively combined with molecular and cytogenetic parameters.

Entities:  

Mesh:

Year:  1983        PMID: 6605691      PMCID: PMC1916371     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  109 in total

1.  Properties of reticulum cell sarcomas in SJL/J mice. II. Fate of labeled tumor cells in normal and irradiated syngeneic mice.

Authors:  E A Carswell; S P Lerman; G J Thorbecke
Journal:  Cell Immunol       Date:  1976-04       Impact factor: 4.868

2.  Neoplasias and B-cell precursors.

Authors:  M Seligmann
Journal:  Nature       Date:  1979-06-14       Impact factor: 49.962

3.  Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation.

Authors:  D W Hanto; G Frizzera; K J Gajl-Peczalska; K Sakamoto; D T Purtilo; H H Balfour; R L Simmons; J S Najarian
Journal:  N Engl J Med       Date:  1982-04-15       Impact factor: 91.245

4.  Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody.

Authors:  E S Vitetta; D Yuan; K Krolick; P Isakson; M Knapp; S Slavin; S Strober
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

5.  Immunopathology of B-cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV).

Authors:  P K Pattengale; C R Taylor; P Twomey; S Hill; J Jonasson; T Beardsley; M Haas
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

Review 6.  Do natural killer cells engage in regulated reactions against self to ensure homeostasis?

Authors:  G Cudkowicz; P S Hochman
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

7.  Genetic control by the hr-locus of susceptibility and resistance to leukemia.

Authors:  H Meier; D D Myers; R J Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1969-07       Impact factor: 11.205

8.  Quantitative immunofluorescent analysis of surface phenotypes of murine B cell lymphomas and plasmacytomas with monoclonal antibodies.

Authors:  L L Lanier; N L Warner; J A Ledbetter; L A Herzenberg
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

9.  Expression of Ly 1, Ly 2, Thy 1, and TL differentiation antigens on mouse T-cell tumors.

Authors:  B J Mathieson; P S Campbell; M Potter; R Asofsky
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  Chronic allogeneic disease. II. Development of lymphomas.

Authors:  M Y Armstrong; E Gleichmann; H Gleichmann; L Beldotti; J Andre-Schwartz; R S Schwartz
Journal:  J Exp Med       Date:  1970-09-01       Impact factor: 14.307

View more
  35 in total

1.  Splenic marginal zone lymphomas of mice.

Authors:  T N Fredrickson; K Lennert; S K Chattopadhyay; H C Morse; J W Hartley
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

2.  Anaplastic plasmacytoma of mouse--establishing parallels between subtypes of mouse and human plasma cell neoplasia.

Authors:  Daphne de Jong; Siegfried Janz
Journal:  J Pathol       Date:  2010-07       Impact factor: 7.996

3.  SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus.

Authors:  B Hallberg; J Schmidt; A Luz; F S Pedersen; T Grundström
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  The influence of H-2 genetic factors on the development of benign monoclonal gammopathy in ageing H-2 congenic C57BL and BALB mice.

Authors:  T W van den Akker; A P Tio-Gillen; R Benner; C Zurcher; J Radl
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

5.  Intimate host-tumor interaction in the spontaneous reticulum cell sarcoma of SJL/J mice: is it an exceptional case?

Authors:  B Bonavida
Journal:  Surv Immunol Res       Date:  1985

6.  Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model.

Authors:  E V Schmidt; P K Pattengale; L Weir; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.

Authors:  S C Lawrenz-Smith; A C Massey; D J Innes; C Y Thomas
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Identifying and Implementing Endpoints for Geriatric Mice.

Authors:  Linda A Toth
Journal:  Comp Med       Date:  2018-11-28       Impact factor: 0.982

9.  Identification of a common viral integration region in Cas-Br-E murine leukemia virus-induced non-T-, non-B-cell lymphomas.

Authors:  D Bergeron; L Poliquin; C A Kozak; E Rassart
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

Review 10.  Mouse models for radiation-induced cancers.

Authors:  Leena Rivina; Michael J Davoren; Robert H Schiestl
Journal:  Mutagenesis       Date:  2016-05-21       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.